Continuous and bimonthly publication
ISSN (on-line): 1806-3756

Licença Creative Commons
18263
Views
Back to summary
Open Access Peer-Reviewed
Artigo Especial

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey

Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: um inquérito mundial

Massimo Amicosante1,2A, Lia D'Ambrosio3,4, Marcela Munoz5, Fernanda Carvalho de Queiroz Mello6, Marc Tebruegge7,8,9, Novel Njweipi Chegou10, Fouad Seghrouchni11, Rosella Centis3, Delia Goletti12, Graham Bothamley13, Giovanni Battista Migliori3, TB Diagnostic Survey Working Group

DOI: http://dx.doi.org/10.1590/S1806-37562017000000219

1. Dipartimento di Biomedicina e Prevenzione, Università degli Studi di Roma "Tor Vergata", Roma, Italia.
2. ProxAgen OOD, Sofia, Bulgaria.
3. WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italia.
4. Public Health Consulting Group SAGL, Lugano, Switzerland.
5. Clínica en Tuberculosis y Enfermedades Pleurales, Instituto Nacional de Enfermedades Respiratorias - INER - Ciudad de México, México.
6. Instituto de Doenças do Tórax, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro (RJ) Brasil.
7. Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
8. Department of Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
9. Great Ormond Street Hospital Institute of Child Health, University College London, London, United Kingdom.
10. SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
11. National Institute of Hygiene, Rabat, Morocco.
12. Unità di Ricerca Translazionale, Dipartimento di Epidemiologia e Ricerca Preclinica, Istituto Nazionale per le Mallatie Infettive - INMI - Lazzaro Spallanzani, Roma, Italia.
13. Homerthon University Hospital, London, United Kingdom.
A. Publicação póstuma.
Recebido: 29 junho 2017.
Aprovado: 3 setembro 2017.
Estudo realizado pelo TB Diagnostic Survey Working Group.

Endereço para correspondência:
Giovanni Battista Migliori. WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italia.
Tel.: 39 0331 829404. Fax: 39 0331 829402. E-mail: giovannibattista.migliori@fsm.it
Apoio financeiro: Nenhum.

Indexes

Development by:

© All rights reserved 2024 - Jornal Brasileiro de Pneumologia